Prefenidone

prefenidone, for those not familiar, that's marketed by roshit's been on the market for a few years. It retains the pharmacology profinitum, but it has range of potential benefits including enhanced exposure and improved tolerability. Up to 53% of mild, moderate and severe covid patients actually show signs of lung fibroses three weeks after a symptom onset.